Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Long-term Safety of Fentora for Breakthrough Cancer Pain
NCT00105937Phase 3Completed
- Sponsor
- Cephalon, Inc.
- Start
- Apr 2004
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 3 trial of fentanyl in breakthrough pain, sponsored by Cephalon, Inc.. Started Apr 2004; status: completed.
02
Drugs
fentanyl
03
Conditions
breakthrough pain
Beyond the preview
Go deeper on NCT00105937.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00105937.